Unknown

Dataset Information

0

Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005-2014.


ABSTRACT:

Background

The American Diabetes Association (ADA) recommends that treatment with metformin be considered for prevention of type 2 diabetes in persons with prediabetes. However, metformin use outside the setting of diagnosed diabetes in US adults is not well characterized.

Objective

To examine trends in self-reported prediabetes and treatment with metformin. We also compared characteristics of adults self-reported prediabetes who were vs. were not taking metformin.

Design

Cross-sectional analysis.

Participants

Adults ? 20 years of age who participated in the 2005-2014 National Health and Nutrition and Examination Survey (NHANES), n = 28,461.

Approach

We characterized trends in self-reported prediabetes and metformin use in this population. We used multiple logistic regression models to identify predictors of metformin use among adults with self-reported prediabetes. All analyses accounted for the weighted complex survey design to generate nationally representative estimates.

Key results

The prevalence of self-reported prediabetes increased from 5.1% in 2005-2006 to 7.4% in 2013-2014 (P-for-trend < 0.001). In persons with self-reported prediabetes, metformin use increased, from 2.4 to 8.3% (P-for-trend = 0.013). Adults who were taking metformin were more likely to be obese and to report trying to lose weight in the past year.

Conclusions

Self-reported prediabetes has increased in the past decade. Metformin use in the setting of prediabetes has also increased but remains relatively uncommon at 8% in adults who self-report prediabetes, despite current clinical recommendations.

SUBMITTER: Liu C 

PROVIDER: S-EPMC6957593 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005-2014.

Liu Caroline C   Foti Kathryn K   Grams Morgan E ME   Shin Jung-Im JI   Selvin Elizabeth E  

Journal of general internal medicine 20191021 1


<h4>Background</h4>The American Diabetes Association (ADA) recommends that treatment with metformin be considered for prevention of type 2 diabetes in persons with prediabetes. However, metformin use outside the setting of diagnosed diabetes in US adults is not well characterized.<h4>Objective</h4>To examine trends in self-reported prediabetes and treatment with metformin. We also compared characteristics of adults self-reported prediabetes who were vs. were not taking metformin.<h4>Design</h4>C  ...[more]

Similar Datasets

| S-EPMC5481991 | biostudies-literature
| S-EPMC9136916 | biostudies-literature
| S-EPMC5498183 | biostudies-literature
| S-EPMC3828579 | biostudies-literature
| S-EPMC4135501 | biostudies-literature
| S-EPMC4194078 | biostudies-literature
| S-EPMC8772274 | biostudies-literature
| S-EPMC6708260 | biostudies-literature
| S-EPMC5749469 | biostudies-literature
| S-EPMC6988737 | biostudies-literature